Last reviewed · How we verify

Renin-Angiotensin (RAAS) alone

James A. Tumlin, MD · FDA-approved active Small molecule

Renin-Angiotensin (RAAS) alone is a RAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist) Small molecule drug developed by James A. Tumlin, MD. It is currently FDA-approved for Hypertension, Heart failure, Chronic kidney disease. Also known as: Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,.

RAAS inhibitors block the renin-angiotensin-aldosterone system to reduce blood pressure and protect organs from hypertension-related damage.

RAAS inhibitors block the renin-angiotensin-aldosterone system to reduce blood pressure and protect organs from hypertension-related damage. Used for Hypertension, Heart failure, Chronic kidney disease.

At a glance

Generic nameRenin-Angiotensin (RAAS) alone
Also known asLispril, Enalapril, Perindopril, Losarta, Valsar etc.,
SponsorJames A. Tumlin, MD
Drug classRAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist)
TargetRenin-angiotensin-aldosterone system components (ACE, AT1 receptor, renin, or aldosterone receptor)
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

The renin-angiotensin-aldosterone system (RAAS) is a hormonal cascade that regulates blood pressure and fluid balance. RAAS inhibitors (including ACE inhibitors, ARBs, direct renin inhibitors, and aldosterone antagonists) interrupt this pathway at various points, reducing vasoconstriction and aldosterone-mediated sodium retention, thereby lowering blood pressure and reducing proteinuria. These agents are used alone or in combination for cardiovascular and renal protection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Renin-Angiotensin (RAAS) alone

What is Renin-Angiotensin (RAAS) alone?

Renin-Angiotensin (RAAS) alone is a RAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist) drug developed by James A. Tumlin, MD, indicated for Hypertension, Heart failure, Chronic kidney disease.

How does Renin-Angiotensin (RAAS) alone work?

RAAS inhibitors block the renin-angiotensin-aldosterone system to reduce blood pressure and protect organs from hypertension-related damage.

What is Renin-Angiotensin (RAAS) alone used for?

Renin-Angiotensin (RAAS) alone is indicated for Hypertension, Heart failure, Chronic kidney disease, Post-myocardial infarction, Diabetic nephropathy.

Who makes Renin-Angiotensin (RAAS) alone?

Renin-Angiotensin (RAAS) alone is developed and marketed by James A. Tumlin, MD (see full James A. Tumlin, MD pipeline at /company/james-a-tumlin-md).

Is Renin-Angiotensin (RAAS) alone also known as anything else?

Renin-Angiotensin (RAAS) alone is also known as Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,.

What drug class is Renin-Angiotensin (RAAS) alone in?

Renin-Angiotensin (RAAS) alone belongs to the RAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist) class. See all RAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist) drugs at /class/raas-inhibitor-ace-inhibitor-arb-direct-renin-inhibitor-or-aldosterone-antagonist.

What development phase is Renin-Angiotensin (RAAS) alone in?

Renin-Angiotensin (RAAS) alone is FDA-approved (marketed).

What are the side effects of Renin-Angiotensin (RAAS) alone?

Common side effects of Renin-Angiotensin (RAAS) alone include Cough (ACE inhibitors), Hyperkalemia, Dizziness, Fatigue, Angioedema.

What does Renin-Angiotensin (RAAS) alone target?

Renin-Angiotensin (RAAS) alone targets Renin-angiotensin-aldosterone system components (ACE, AT1 receptor, renin, or aldosterone receptor) and is a RAAS inhibitor (ACE inhibitor, ARB, direct renin inhibitor, or aldosterone antagonist).

Related